Abstract
Background
Preeclampsia remains a disease of theories as the real aetiology has remained elusive. Altered nitric oxide production has been associated with preeclampsia although conflicting results showing elevation, decrease or no change in nitric oxide levels have emerged from previous studies.
Objective
The aim of the study was to measure the serum levels of nitrate and nitrite in normal pregnancies and pregnancies complicated by pre-eclampsia.
Materials and methods
Venous blood was extracted from 39 normal pregnant women (control) and 34 women with preeclampsia (study group). Serum concentrations of nitrate and nitrite were determined using the HPLC method. Other special investigations including renal function tests were performed. The patients were managed according to protocol and the outcome of the pregnancies evaluated.
Results
There was no significant difference in the mean maternal age and gestational age at delivery between the groups. However the mean systolic and diastolic blood pressure of the study group (150.5 mmHg and 98.8 mmHg) were significantly higher than the levels in the control group, (110.86 and 85.5), p<0.0001. There was no significant difference in the mean serum nitrate levels (19.157±13.407 vs. 19.189±16.805) p=0.993. The fetal and maternal outcomes were comparable.
Conclusion
Our study has demonstrated that there was no alteration in nitric oxide production in preeclampsia, thus contributing to the existing unresolved role of nitric oxide in the pathogenesis of preeclampsia. Further research is called for.
Similar content being viewed by others
References
Ahokas RA, Lubarsky SL, Park GC, Friedman SA, Sibai BM (1998) Chronic nitric oxide synthesis inhibition does not prevent pregnancy vasodilation in the rat. Hypertens Pregnancy 17:55–68
American College of Obstetricians and Gynecologists (2002) Practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 99:159–167
Ayuk PT, Theophanous D, D'Souza SW, Sibley CP, Glazier JD (2002) L-arginine transport by the microvillous plasma membrane of the syncytiotrophoblast from human placenta in relation to nitric oxide production: effects of gestation, preeclampsia and intrauterine growth restriction J Clin Endocrinol Metab 87:747–751
Benedetto C, Marozio L, Neri I, Giarola M, Volpe A, Facchinetti F (2000) Increased L-citrulline/L-arginine plasma ratio in severe preeclampsia. Obstet Gynecol 96:395–399
Branch DW, Porter TF (1999) Hypertensive disorders in pregnancy. In: Scott JR, DiSaia PJ, Hammond CB, Spellacy WN (eds) Danforth's obstetrics and gynecology. Lippincott Williams and Wilkins, Philadelphia, pp 309–326
Buhimschi I, Yallampalli C, Chwalisz K, Garfield RE (1995) Preeclampsia-like conditions produced by nitric oxide inhibition: effects of L-arginine, D-arginine and steroid hormones. Hum Reprod 10:2723–2730
Chwalisz K, Buhimischi I, Garfield RE (1996) Role of nitric oxide in obstetrics. Prenat Neonat Med 292–328
Clark BA, Halverson L, Sachs B, Epstein FH (1992) Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol 166:962–968
Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC III, Hauth JC, Wenstrom KD (2001) Hypertensive disorders in pregnancy. In: Williams' obstetrics, 21st edn. McGraw Hill, New York, pp 567–618
Curtis NE, Girde NM, King RG, Marriot PJ, Rook TJ, Brennecke SP (1995) Nitric oxide metabolites in normal human pregnancy and preeclampsia. Hypertens Pregnancy 14:339–349
Davidge ST, Stranko CP, Roberts JM (1996) Urine but not plasma nitric oxide metabolites decreased in women with preeclampsia. Am J Obstet Gynecol 174:1008–1013
Dekker GA (1999) Risk factors for preeclampsia. Clin Obstet Gynecol 42:422–435
Dekker GA, Sibai BM (1998) Etiology and pathophysiology of preeclampsia. Current concepts. AJOG review. Am J Obstet Gynecol 179:1359–1375
Di Iorio R, Marinoni E, Emiliani S, Villaccio B, Cosmi EV (1998) Nitric oxide in preeclampsia: lack of evidence for decreased production. Eur J Obstet Gynecol Reprod Biol 76:65–70
Diket AL, Pierce MR, Munshi UK, Voelker CA, Eloby-Childress S, Greenberg SS et al (1994) Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruption in rats. Am J Obstet Gynecol 171:1243–1250
Ellis J, Wennerholm UB, Bengtsson A, Lilja H, Pettersson A, Sultan B, Wennergren M, Hagberg H (2001) Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 80:602–608
Faxen M, Nisell H, Kublickiene KR (2001) Altered mRNA expression of ecNOS and iNOS in myometrium and placenta from women with preeclampsia. Arch Gynecol Obstet 265:45–50
Helmbrecht GD, Farhat GS et al (1996) L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am J Obstet Gynecol 175:800–805
Jo T, Takauchi Y, Nakajima Y, Fukami K, Kosaka H, Terada N (1998) Maternal or umbilical venous levels of nitrite/nitrate during pregnancy and at delivery. In Vivo 12:523–526
Lopez-Jaramillo P, Narvaez M, Calle A, Rivera J, Jacome P, Ruano C et al (1996) Cyclic guanosine 3'5'monophosphate concentrations in preeclampsia: effects of hydralazine. Br J Obstet Gynaecol 103:33–38
Lyall F, Young A, Greer IA (1995) Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 173:714–718
Menyawi El, Looreesuwan S, Knapp S, Thalhammer F, Stoiser B, Burgmann H (1998) Measurement of serum nitrite/nitrate concentrations using high performance liquid chromatography. J Chromatogr B 706:347–351
Molnar M, Suto T, Toth T, Hertelendy F (1994) Prolonged blockage of nitric oxide synthesis in gravid rats produce sustained hypertension, proteinuria, thrombocytopenia and intrauterine growth retardation. Am J Obstet Gynecol 170:1458–1466
Moncada S, Plamer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109–142
Nobunaga T, Tokugawa Y, Hashimoto K, Kimura T, Matsuzaki N, Nitta Y et al (1996) Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest 41:189–193
Norwitz ER, Robinson JN, Repke JT (1999) Prevention of preeclampsia: is it possible. Clin Obstet Gynecol 42:436–454
Ranta V, Viinikka L, Halmesmaki E, Ylikorkala O (1999) Nitric oxide production with preeclampsia. Obstet Gynecol 93:442–445
Rowe J, Campbell S, Gallery ED (2001) Plasma from preeclamptic women stimulates decidual endothelial cell growth and prostacyclin but not nitric oxide production: close correlation of prostacyclin and thromboxane production. J Soc Gynecol Investig 8:32–38
Scalera F, Schlembach D, Beinder E (2001) Production of vasoactive substances by human umbilical vein endothelial cells after incubation with serum from preeclamptic patients. Eur J Obstet Gynaecol Reprod Biol 99:172–178
Seligman SP, Buyan JP, Clancy RM, Young BK, Abramson SB (1994) The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 171:944–948
Senior K (2001) A possible molecular explanation for preeclampsia. Lancet 357:1857
Shaamash AH, Elsonosy ED, Zakhari MM, Radwan Sh H, El-Dien HM (2001) Placental nitric oxide synthase (NOS) activity and nitric oxide (NO) production in normal pregnancy, preeclampsia and eclampsia. Int J Gynecol Obstet 72:127–133
Silver RK, Kupfermink MJ, Russel TL, Adler L, Mullen TA, Caplan MS (1996) Evaluation of nitric oxide as a mediator of severe preeclampsia. Am J Obstet Gynecol 174:1013–1017
Smarason AK, Allman KG, Young D, Redman CWG (1997) Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with preeclampsia. Br J Obstet Gynaecol 104:538–543
Steinert JR, Wyatt AW, Postan L, Jacob R, Mann GE (2002) Preeclampsia is associated with altered Ca2+ regulation and NO production in human fetal endothelial cells. FASEB J 16:721–723
Taylor RN, Varma M, Teng NN, Roberts JM (1990) Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 71:1675–1677
Tsikas D, Rossa S, Sandmann J, Frolich JC (1999) High performance liquid chromatographic analysis of nitrite and nitrate in human plasma as S-nitroso-N-acetylcysteine with ultraviolet absorbance detection. J Chromatogr B 726:199–201
Tyurin VA, LiuSX, Tyurina YY, Sussman NB, Hubel CA, Roberts JM, Taylor RN, Kagan VE (2001) Elevated levels of S-nitrossoalbumin in preeclampsia plasma. Circ Res 88:1210–1215
Vural P (2002) Nitric oxide/endothelin-1 in preeclampsia. Clin Chim Acta 317:65–70
Yallampalli C, Garfield RE (1993) Inhibition of nitric oxide synthesis in rats during pregnancy produced signs similar to those of preeclampsia. Am J Obstet Gynecol 169:1316–1320
Yanik FF, Amanvermez R, Koca KI, Yanik A, Celik C (2001) Serum nitric oxide and glutathione levels in preeclamptic and normotensive women during labour. Gynecol Obstet Invest 51:110–115
Ylikorkala O, Viinikka L (1992) The role of prostaglandins in obstetrical disorders. Clin Obstet Gynecol 6:809–827
Acknowledgements
We are greatly indebted to our colleagues at Maternity Hospital for allowing us to include their patients in our study. We are also grateful to the laboratory staff of the department for their role in the analysis of the samples and to Madam Asiya T Mohd for her assistance in the preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Diejomaoh, F.M.E., Omu, A.E., Al-Busiri, N. et al. Nitric oxide production is not altered in preeclampsia. Arch Gynecol Obstet 269, 237–243 (2004). https://doi.org/10.1007/s00404-002-0465-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-002-0465-6